Targeting histone acetylation/deacetylation in parasites: an update (2017–2020)
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 57, 65-74
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro
- AIRC (IG19162 IG19162)
- Italian Ministry for University and Research (PRIN2016-20152TE5PK_004)
- Italian Ministry of Health (PE-2013-02355271)
- Sapienza University of Rome (RM11715C7CA6CE53)
This publication has 61 references indexed in Scilit:
- Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoniPLOS Pathogens, 2013
- Schistosoma mansoni Sirtuins: Characterization and Potential as Chemotherapeutic TargetsPLOS Neglected Tropical Diseases, 2013
- HDAC inhibitors in parasitic diseasesImmunology & Cell Biology, 2011
- Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?Trends in Parasitology, 2011
- Novel 3-Arylideneindolin-2-ones as Inhibitors of NAD+-Dependent Histone Deacetylases (Sirtuins)Journal of Medicinal Chemistry, 2009
- Bisnaphthalimidopropyl Derivatives as Inhibitors of Leishmania SIR2 Related Protein 1ChemMedChem, 2009
- Novel Inhibitor of Plasmodium Histone Deacetylase That Cures P. berghei- Infected MiceAntimicrobial Agents and Chemotherapy, 2009
- The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoniBiochemical and Biophysical Research Communications, 2008
- Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase InhibitorsAntimicrobial Agents and Chemotherapy, 2008
- Differential effects of polyamine derivative compounds against Leishmania infantum promastigotes and axenic amastigotesInternational Journal for Parasitology, 2005